Literature DB >> 24535579

Repression of interferon regulatory factor 3 by the Epstein-Barr virus immediate-early protein Rta is mediated through E2F1 in HeLa cells.

Liang-Hua Zhu1, Shan Gao1, Rui Jin1, Li-Li Zhuang1, Li Jiang1, Ling-Zhi Qiu1, Hua-Guo Xu2, Guo-Ping Zhou1.   

Abstract

Interferon regulatory factor 3 (IRF-3), an essential transcriptional regulator of the interferon (IFN) genes, is important in the host defense against viral and microbial infection. Epstein-Barr virus (EBV) immediate-early protein replication and transcription activator (Rta) and the transcription factor E2F1 are two important inhibitive factors, which repress IRF-3 expression. Numerous studies have identified that Rta can directly bind to the Rta-response element in promoters of its target genes and regulate their expression. In the present study, we demonstrated that Rta represses the expression of IRF-3 by E2F1 rather than through its traditional way. Transient transfection analysis and chromatin immunoprecipitation (ChIP) assays revealed that the overexpression of Rta elevated the expression of E2F1 and increased the binding of E2F1 to the promoter of IRF-3. The mutation of the E2F1‑binding site and the knocking down of E2F1 by small interfering RNA (siRNA) can eradicate the inhibitory effect of Rta. These results suggested that Rta represses IRF-3 expression by increasing E2F1 binding to the IRF-3 promoter.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535579     DOI: 10.3892/mmr.2014.1957

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.

Authors:  XueQiao Liu; Tomohiko Sadaoka; Tammy Krogmann; Jeffrey I Cohen
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

2.  Transcription factor E2F1 positively regulates interferon regulatory factor 5 expression in non-small cell lung cancer.

Authors:  Dan-Dan Feng; Qian Cao; Dao-Qi Zhang; Xiao-Lu Wu; Cai-Xia Yang; Yu-Fei Chen; Tang Yu; Hai-Xiao Qi; Guo-Ping Zhou
Journal:  Onco Targets Ther       Date:  2019-08-23       Impact factor: 4.147

3.  Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.

Authors:  Michael George Botelho; Kit-San Yuen; Dong-Yan Jin; Sonia Jangra; Aradhana Bharti; Wai-Yin Lui; Vidyanath Chaudhary
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.